PhD. Henrik Bjørn Nielsen
Chief Scientific Officer, Clinical-Microbiomics A/S
H. Bjørn Nielsen, PhD, Chief Scientific Officer at Clinical-Microbiomics A/S, has since 2008 been a frontrunner in the field of microbiome research, leading to a series of important scientific discoveries including his pioneering work on identification of metagenomic species by co-abundance binning, and a three-pronged association study that links microbiome, serum metabolome and clinical data in pre-diabetic Danes. Current research explores concepts and biology using ultra-high-resolution microbiomics.